Bubs management no better if they are getting into bed with this tin pot show. Fonterra didnt do there homework fair enough. Most companies who deal with china in the niche product space leave with there tail between there legs. Bellamys tried but with continual import bans due to " labelling issues" they tanked the share price 80% then bought the company for a song.
Ann: MOU to Manufacture SAMR Infant Formula in China, page-123
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
17.0¢ |
Change
-0.005(2.86%) |
Mkt cap ! $151.8M | |||
| Open | High | Low | Value | Volume |
| 17.5¢ | 18.0¢ | 17.0¢ | $91.61K | 522.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 26 | 1899644 | 17.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.5¢ | 57813 | 3 |
View Market Depth
| Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
| BUB (ASX) Chart |